AD is marked by extracellular amyloid beta (Aβ) accumulation, a byproduct of abnormal amyloid precursor protein (APP) processing via β-secretase and γ-secretase, and intracellular neurofibrillary tangles formed from tau protein. The gene discussed is APP; the disease is Alzheimer disease.